Author:
Abbi Kamal K.S.,Rybka Witold,Ehmann W. Christopher,Claxton David F.
Subject
Cancer Research,Oncology,Hematology
Reference31 articles.
1. Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial;Archimbaud;J Clin Oncol,1995
2. Successful re-induction therapy for acute myelogenous leukemia with cytosine arabinoside and daunorubicin;Stein;Cancer Treat Rep,1979
3. Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities;Kern;Leukemia,2000
4. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study;Tallman;Cancer,1999
5. Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (MECA) in refractory and relapsed acute leukemia;Ferra;Leuk Lymphoma,2000
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献